ACAT1 and metabolic syndrome: While dyslipidemia and cholesterol accumulation have been strongly implicated in promoting pathological NV in models of subretinal NV15, not much is known about role of cholesterol metabolism, activation of ACAT1/SOAT1, and CE formation in pathological RNV during ischemic retinopathy.